Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000980

Drug Information
NameFluspirilene    
SynonymsHMS1791D05; Bio-0707; McN-JR-6218; HMS1570F14; CID3396; Fluspirilene [USAN:INN:BAN]; EU-0100518; 1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4,4-bis(p-fluorophenyl)butyl)-1-phenyl-; F100_SIGMA; AC1L1FUB; BSPBio_001343; Imap; NCGC00093913-02; NCGC00015424-08; Prestwick2_000906; Fluspirileno [INN-Spanish]; AB00513956; Prestwick0_000906; D02629; CHEMBL46516; DB04842; R6218; HMS1989D05; NCGC00093913-04; 8-[4,4-bis(4-fluorophenyl)butyl]-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one; C29H31F2N3O; NCGC00015424-02; NCGC00093913-01; Prestwick1_000906; 1-Phenyl-4-oxo-8-(4,4-bis(4-fluorophenyl)butyl)-1,3,8-triazaspiro(4,5)decane; BRN 0633853; Redeptin; BRD-K77947974-001-04-9; SMR000058304; MLS000069357; Lopac-F-100; 1841-19-6; 5-26-04-00097 (Beilstein Handbook Reference); Lopac0_000518; 8-(4,4-Bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazaspiro-(4.5)decan-4-one; 1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4,4-bis(4-fluorophenyl)butyl)-1-phenyl-; NCGC00016595-01; Prestwick3_000906; 1,3,8-Triazaspiro[4.5]decan-4-one, 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-; Fluspirilene; SPBio_002951; R 6218; HMS2089C15; Spirodiflamine; Fluspirilenum; CAS-1841-19-6; L001195; NCGC00015424-01; Fluspirilen; NCGC00093913-03; NCGC00093913-05; MLS001333730; F-100; Fluspirilene (USAN/INN); 8-[4,4-bis (p-fluorophenyl)butyl]- 1-phenyl-1,3,8-triazino[4,5]decan-4-one; 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one; EINECS 217-418-6; Fluspirilenum [INN-Latin]; spiropiperidine analogue, 1; Oprea1_804941; 8-[4,4-bis(p-Fluorophenyl)butyl]-1-phenyl-1,3,8-triazino[4.5]decan-4-one; LS-154759; MolPort-002-540-769; Fluspirileno; BPBio1_000828; Imap (TN); BSPBio_000752    
CompanyJanssen Pharmaceutica    
IndicationSchizophreniaApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntipsychotic Agents    
CAS NumberCAS 1841-19-6
FormularC29H31F2N3O    
PubChem Compound IDCID 3396.    
PubChem Substance IDSID 159093.    
SuperDrug ATC IDN05AG01;    
SuperDrug CAS ID001841196;    
TargetD(2) dopamine receptorAntagonist[2]
Ref 1Drug information of Fluspirilene, 2008 To Reference
Ref 2Inhibition of glutamate release by fluspirilene in cerebrocortical nerve terminals (synaptosomes). Synapse. 2002 Apr;44(1):36-41. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543